Reston Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Reston Wealth Management's LLY Position: Q2 2026 in Review
Reston Wealth Management increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $213K and bringing the position to 1,092 shares worth $1.31M. The position accounts for 0.35% of the portfolio, ranked #22.
Reston Wealth Management first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Reston Wealth Management held 1,092 shares of Eli Lilly worth $1.31M as of Q2 2026.
- Reston Wealth Management bought 208 Eli Lilly shares in Q2 2026, an estimated $213K.
- Eli Lilly made up 0.35% of Reston Wealth Management's portfolio in Q2 2026, its #22 holding.
- Reston Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Reston Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.